Marc Güell

Marc Güell is a prominent researcher in the field of synthetic biology and gene editing, currently serving as a professor at Pompeu Fabra University (UPF) in Spain. He leads a research group focused on translational synthetic biology, emphasizing the development of innovative genetic therapies. Güell has been involved in breakthrough studies, including those utilizing CRISPR technology, which aim to correct genetic mutations that cause rare metabolic disorders. His work is instrumental in advancing personalized medicine and offers hope for patients suffering from extremely rare genetic conditions.